An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with Erythropoietic Protoporphyria (EPP)

Project: Research project

Project Details

StatusActive
Effective start/end date3/26/243/25/29

Funding

  • Disc Medicine Inc: $12,469.23